Shanghai Jiaotong University Dong Tao's team has made new progress in the study of the mechanism of environmental influence on bacterial competition
Time of Update: 2022-04-20
Recently, Dong Tao's team from the School of Life Science and Technology of Shanghai Jiao Tong University and the State Key Laboratory of Microbial Metabolism revealed that environmental factors determine the survival mechanism of bacteria in the competition mediated by the type VI protein secretion system (T6SS) .
Early detection of bacteria in patients with new coronary pneumonia and influenza pneumonia tracheal intubation: a European multicenter cohort study
Time of Update: 2021-09-28
An article published in the American Journal of Respiratory and Critical Care Medicine , an authoritative respiratory journal, analyzes the early bacterial detection of patients with new coronary pneumonia intubation caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with influenza pneumonia Outcome rate, as well as microbiological characteristics and their impact on prognosis .
Brit J Cancer: Are gallstone disease and bililin levels associated with colorectal cancer risk
Time of Update: 2021-01-17
epidemiological findings on the link between gallstone disease and circulatory bilium levels and colorectal cancer (CRC) risk were not consistent.
despite the scale of the study, the researchers found no evidence of a causal link between circulating bilirubin levels or gallstone disease and the risk of CRC.
Siromos's treatment of IBM is forward-looking in its efficacy and safety
Time of Update: 2020-11-01
four patients in the Siromos group were treated for adverse reactions (severe mouth ulcers, sterile pneumonia, renal insufficiability and lower limb edema) and recovered after discontinuation of treatment.
NEJM Heavyweight: 2 years in advance! Wu Yilong, in a team of 284 centers around the world and in China, found that surgery and precision-type targeted therapy reduced the risk of recurrence of early
Time of Update: 2020-10-04
In summary, the study found that in NSCLC patients who were positive for EGFR mutations in periods IB to IIIA, patients who received oxytinib had significantly longer disease-free survival than those who received placebo (for patients with early and mid-stage lung cancer from IB to IIIA with a drive gene mutation, their risk of tumor recurrence decreased by 83 percentage points after pre-surgical removal with the help of third-generation targeted drugs).